RIVERSIDE, Calif.--(BUSINESS WIRE)--ieCrowd, the discovery-to-market commercialization platform for innovations with the potential to solve global challenges, today announced plans to commercialize a new class of intelligent supplemental oxygen devices. Once commercialized the devices will integrate new technologies for delivering demand-driven and efficient oxygen flow to people living with chronic lung diseases. ieCrowd acquired the exclusive license for the innovation’s underlying technology from University of California, San Diego, where the first prototype had been developed to address significant inefficiencies in supplemental oxygen devices on the market today. The technology is being commercialized by Breathing Technologies Inc. (BTI), a new subsidiary company formed by ieCrowd.
Millions of people today suffer from chronic lung diseases such as COPD, severe asthma, cystic fibrosis and lung cancer, all of which result in low blood oxygen levels and severely limit daily activity. The problem continues to grow – COPD is the third most common cause of death in the U.S. today with approximately 14 million COPD patients and the number two cause of death in China, with more than 40 million afflicted. ieCrowd plans to include features designed for use by patients around the world – including in countries that to date have had limited access to oxygen therapy options.
“Existing oxygen delivery devices make it challenging to accurately address an individual patient’s need for oxygen in real time,” said Stephen Abbott, ieCrowd’s Chief Discovery Officer. “Our oxygen therapy device is being designed to provide a new, real-world solution that automatically and intelligently optimizes and automates the oxygen delivery process. This could simplify the patient’s use of supplemental oxygen expanding mobility and range, encouraging movement and activity, and reducing costs – all of which are important pieces to improving quality of life for patients.”
A human clinical trial of the device was just completed at the Pulmonary Rehabilitation Clinic at UC San Diego Medical Center. Publication of the results from the trial are pending. Funding for the trial was provided by the University of California Proof of Concept Program.
Targeted to become the market’s first smart, adaptive oxygen delivery system, the device uses a patient’s real-time oxygen requirements, based on sensor feedback and computer algorithms, to establish a user’s oxygen demand. The innovation is being developed to meet a patient’s oxygen requirements based on changing demands throughout the day. Current systems deliver oxygen based on regulator presets and patient adjustments, often creating a burden to the patient, shorter tank lifecycles, limited mobility ranges, and imprecise therapy.
The technology’s development also includes plans to enable communication to mobile devices and the cloud for the monitoring of patient data generated by the device. The sharing of patient-generated data with an individual’s medical providers and others involved in treatment means the device could become an important element of the growing ecosystem of Internet of Things (IoT)-connected medical devices. Through this constant information sharing, ieCrowd believes medical and treatment providers will have a better understanding of unique patient needs and will be able to improve care while reducing costs accordingly.
Breathing Innovation Discovery and University Partnership
The device’s underlying technology was developed on the UC San Diego campus by David Lischer and co-inventor Dr. Steve Roberts, PhD EE. Lischer had been diagnosed with COPD and was seeking ways to expand mobility and quality of life that had been restricted by his limited lung capacity. Lischer, who has 30-40 percent lung capacity, uses a prototype daily that enables him to maintain an active lifestyle which includes golf and working on his ranch.
“We are proud to have a premier research institution like UC San Diego become an Innovation Partner of ieCrowd,” said Amro Albanna, founding chairman and CEO of ieCrowd. “This is another great example of how working together we can transform promising discoveries into solutions that have significant potential to benefit the world.”
“Making the value in this technology available to the millions of potential patients in the U.S. and abroad is a fantastic outcome of UC San Diego’s research mission,” said David Gibbons, Assistant Director of Technology Transfer and IP, UC San Diego. “As with any successful university derived product, the benefits here include not only long-term revenue, but also the tangible positive impact universities can have on everyone, and connections to new people and institutions as the beneficial technology becomes an ambassador for the university.” Gibbons added “ieCrowd’s business model is a very good fit for a university technology transfer office. The university can maintain a focus on basic research and discoveries while ieCrowd builds a business around the innovation to commercialize the discovery for maximum impact in the global market.”
Innovation Economy Corporation’s (DBA ieCrowd) mission is to transform breakthrough life and health discoveries into solutions capable of solving global challenges. ieCrowd's disruptive business model combines entrepreneurship and the collective power of the Crowd. It follows a three-pronged approach by working with research institutions to identify promising technologies, developing a business around the solution and launching products to a global market using strategic partners. The crowd plays an integral role in each stage of ieCrowd’s mission to solve global challenges – from crowd-sourced innovations to crowd-funding, and crowd-supported product development to crowd-sourced market solutions. Founded in 2010, ieCrowd has established a global ecosystem of institutions, government agencies, universities, non-profits, companies and individuals – all committed to supporting ieCrowd’s vision and mission. For more information about ieCrowd visit www.iecrowd.com. Follow us at @ieCrowd, https://linkedin.com/company/iecrowd and https://www.facebook.com/ieCrowd.
To stay up to date on company news sign up for ieCrowd’s newsletter at http://iecrowd.com/our-company.